How Sex and Race/Ethnicity Influence Interventional Cardiology Outcomes: What Do We Know?
Niki Procopi1,2, Francesca Maria Di Muro1, Birgit Vogel1
1Center for Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine at Mount Sinai, New York, New York.
Insights
Interventional cardiology shows significant disparities in care access and outcomes for women and racial/ethnic minorities. Addressing these requires systemic changes beyond just trial enrollment to ensure equitable cardiovascular medicine for all patients.
Area of Science:
- Cardiovascular Medicine
- Health Equity
- Interventional Cardiology
Background:
- Significant disparities persist in interventional cardiology access and outcomes across racial/ethnic and sex groups.
- These inequities stem from biological, structural, and sociocultural factors influencing patient care pathways.
- Underrepresentation of diverse populations in clinical research limits understanding and perpetuates practice gaps.
Purpose of the Study:
- To explore the intersection of social and biological factors in cardiovascular disease risk, presentation, and treatment.
- To examine how these disparities manifest in percutaneous coronary intervention and transcatheter aortic valve replacement.
- To highlight the need for integrating these differences into care to overcome persistent inequities.
Main Methods:
- This is a review article, synthesizing existing knowledge on disparities in interventional cardiology.
- Focuses on the influence of social and biological dimensions on risk, clinical presentation, procedural strategies, and secondary prevention.
- Examines the two most common interventions: percutaneous coronary intervention and transcatheter aortic valve replacement.
Main Results:
- Social and biological factors significantly intersect to affect cardiovascular disease risk and presentation.
- Disparities are evident in treatment allocation, procedural decision-making, and long-term follow-up.
- Current standardized care pathways often fail to address these differences, perpetuating inequities despite technological advances.
Conclusions:
- Advancing equity in interventional cardiology necessitates more than representative trial enrollment.
- Reforms in study design, outcome stratification, and care delivery are crucial.
- Structural changes are required to ensure cardiovascular medicine innovations benefit all patient populations equitably.
Abstract:
Despite substantial advances in interventional cardiology, profound disparities in access to care and clinical outcomes remain across racial/ethnic and sex groups. These inequities arise from a complex interplay of biological differences, structural barriers, and sociocultural determinants that shape disease recognition, treatment allocation, procedural decision-making, and long-term follow-up. A further driver is the limited understanding of cardiovascular disease in female patients and racial/ethnical minorities, largely attributable to their persistent underrepresentation in clinical research, thereby restricting the external validity of evidence and perpetuating gaps in practice. This review explores how social and biological dimensions intersect to influence risk profiles, clinical presentation, procedural strategies, and secondary prevention in contemporary practice, focusing on the 2 most widely performed interventions in cardiology: percutaneous coronary intervention and transcatheter aortic valve replacement. It also highlights how such differences are often not integrated into standardized pathways of care, allowing inequities to persist even in the era of advanced cardiovascular technologies. Ultimately, it may serve as a call to action: advancing equity in interventional cardiology requires more than representative trial enrollment. It demands reform in study design, systematic stratification of outcomes, and structural change in care delivery to ensure that innovations in cardiovascular medicine benefit all patients.
More Related Videos
Related Concept Videos
Stereotypes, Prejudice, and Discrimination
Coronary Artery Disease V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Cardiovascular Drugs: Classification based on Therapeutic Indications
Bias in Epidemiological Studies
Peripheral Artery Disease III: Interprofessional Care


